Takura is a biocell portfolio development company built on Swedish research and innovations.
Cell therapy is the most interesting area within regenerative medicine. Bone marrow-derived mesenchymal stromal cells have anti-inflammatory effects and the possibilities to be used for the treatment of many diseases.
Stem cells have been used ever since the 1950s, when the first bone marrow transplant was done to cure leukemia. The special thing about stem cells is that they can develop into different specific cell types.
Takura's portfolio consists of four cutting edge advanced stem cell therapy companies:
CuraCell (not finalized)